Start Date
5-3-2024 9:10 AM
End Date
5-3-2024 11:00 AM
Description
Background
Problem Statement:
- Dual anti-platelet therapy (DAPT) is a cornerstone in management of many cardiovascular and cerebrovascular conditions; however, inappropriate and prolonged use can lead to increased bleeding risk. Despite guidelines on optimal DAPT duration for various clinical scenarios, a proportion of patients receive inappropriately extended courses of therapy, exposing them to unnecessary risk.
Project AIM:
- We aim to (1) identify inappropriate DAPT use using established clinical guidelines at two academic primary care clinics and (2) develop and implement a targeted best practice advisory (BPA) in EPIC to address gaps in adherence to DAPT guidelines to enhance patient safety and quality of care.
Keywords
quality improvement, healthcare disparities
Included in
Gender and Sexuality Commons, Inequality and Stratification Commons, Medicine and Health Sciences Commons, Race and Ethnicity Commons
May 3rd, 9:10 AM
May 3rd, 11:00 AM
Identifying Inappropriate Dual Anti-Platelet Therapy (DAPT) Utilization in the Outpatient Setting
Background
Problem Statement:
- Dual anti-platelet therapy (DAPT) is a cornerstone in management of many cardiovascular and cerebrovascular conditions; however, inappropriate and prolonged use can lead to increased bleeding risk. Despite guidelines on optimal DAPT duration for various clinical scenarios, a proportion of patients receive inappropriately extended courses of therapy, exposing them to unnecessary risk.
Project AIM:
- We aim to (1) identify inappropriate DAPT use using established clinical guidelines at two academic primary care clinics and (2) develop and implement a targeted best practice advisory (BPA) in EPIC to address gaps in adherence to DAPT guidelines to enhance patient safety and quality of care.
Comments
Quality Improvement 1st Place Award
Presented at the 2024 Jefferson Health Equity and Quality Improvement (HEQI) Summit.